Q96I82 KAZD1_HUMAN
Gene name: KAZALD1
Protein name: Kazal-type serine protease inhibitor domain-containing protein 1
List of terms from Generic GO subset, which this protein is a part of:
- anatomical structure development GO:0048856
- cell differentiation GO:0030154
- extracellular matrix organization GO:0030198
- growth GO:0040007
Table: Top 10 the most similar proteins, based on disordered regions enriched in particular amino acids. Cosine similarity calculation is described here. The whole list can be downloaded at the Download page
| # | UniProt Accession | Gene Name | Cosine Similarity | Generic GO terms |
|---|---|---|---|---|
| 1 | Q9C0E2 | XPO4 | 0.75569 | nucleocytoplasmic transport GO:0006913 protein transport GO:0015031 transport GO:0006810 |
| 2 | Q9Y2Z0 | SUGT1 | 0.75569 | biological process involved in symbiotic interaction GO:0044403 cell cycle GO:0007049 mitotic cell cycle GO:0000278 |
| 3 | Q9NWC5 | TMEM45A | 0.75569 | |
| 4 | O14524 | NEMP1 | 0.72585 | |
| 5 | Q8NEV9 | IL27 | 0.6336 | anatomical structure development GO:0048856 cell differentiation GO:0030154 cell population proliferation GO:0008283 ... |
| 6 | Q9BTA0 | FAM167B | 0.62877 | |
| 7 | Q9H2J4 | PDCL3 | 0.62877 | anatomical structure development GO:0048856 anatomical structure formation involved in morphogenesis GO:0048646 catabolic process GO:0009056 ... |
| 8 | Q86XI2 | NCAPG2 | 0.60455 | anatomical structure development GO:0048856 biosynthetic process GO:0009058 cell cycle GO:0007049 ... |
| 9 | Q8NBI5 | SLC43A3 | 0.59329 | |
| 10 | Q07817 | BCL2L1 | 0.59009 | anatomical structure development GO:0048856 biological process involved in symbiotic interaction GO:0044403 catabolic process GO:0009056 ... |
20 40 60 80 100 AA: MLPPPRPAAALALPVLLLLLVVLTPPPTGARPSPGPDYLRRGWMRLLAEGEGCAPCRPEECAAPRGCLAGRVRDACGCCWECANLEGQLCDLDPSAHFYG STMI: SSSSSSSSSSSSSSSSSSSSSSSSSSSSSS DO_DISOPRED3: DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD.................................................................... DO_IUPRED2A: .............................DDDDDDD................................................................ DO_SPOTD: DDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD................................................................... CONSENSUS: DDD................................................................... CONSENSUS_MOBI: ......................................................................
120 140 160 180 200 AA: HCGEQLECRLDTGGDLSRGEVPEPLCACRSQSPLCGSDGHTYSQICRLQEAARARPDANLTVAHPGPCESGPQIVSHPYDTWNVTGQDVIFGCEVFAYPM STMI: DO_DISOPRED3: .................................................................................................... DO_IUPRED2A: ........................................................D....DD..................................... DO_SPOTD: .................................................................................................... CONSENSUS: .................................................................................................... CONSENSUS_MOBI: ....................................................................................................
220 240 260 280 300 AA: ASIEWRKDGLDIQLPGDDPHISVQFRGGPQRFEVTGWLQIQAVRPSDEGTYRCLGRNALGQVEAPASLTVLTPDQLNSTGIPQLRSLNLVPEEEAESEEN STMI: DO_DISOPRED3: ..............................................................................DDDDDDDDDDDDDDDDDDDDDD DO_IUPRED2A: ........DD...D...DDDD.D.DD............................D.........D....D..D........DDD..DDDDDDDDDDDDDD DO_SPOTD: .............................................................................DDDDDDDDDDDDDDDDDDDDDDD CONSENSUS: ..............................................................................DDDDDDDDDDDDDDDDDDDDDD CONSENSUS_MOBI: .................................................................................................... RICH_[EY]: EEEaEsEEn RICH_fLPS_[E]: rslnlvpEEEaEsEE
AA: DDYY STMI: DO_DISOPRED3: DDDD DO_IUPRED2A: DDDD DO_SPOTD: DDDD CONSENSUS: DDDD CONSENSUS_MOBI: .... RICH_[EY]: ddYY